STOCK TITAN
  1. Home
  2. Sec-filings
  3. EMN
  4. [Form 4] EASTMAN CHEMICAL CO Insider Trading Activity

Eastman Chemical (NYSE: EMN) director defers stock into 1,628 phantom units

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BEGEMANN BRETT D reported acquisition or exercise transactions in this Form 4 filing.

Eastman Chemical director Brett D. Begemann reported a routine compensation transaction involving phantom stock units tied to Eastman Chemical common stock. He received an award of 1,628 Phantom Stock Units, each valued at $73.69, credited under the company’s Directors' Deferred Compensation Plan.

These units are unvested, will vest on May 7, 2027, and are payable only in cash, meaning they do not represent actual shares or voting rights. Following this award, Begemann now holds 60,034 Phantom Stock Units in total, reflecting deferred, cash-settled director compensation rather than an open-market stock purchase.

Positive

  • None.

Negative

  • None.
Insider BEGEMANN BRETT D
Role null
Type Security Shares Price Value
Grant/Award Phantom Stock Units 1,628 $73.69 $120K
Holdings After Transaction: Phantom Stock Units — 60,034 shares (Direct, null)
Footnotes (1)
  1. Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 7, 2027, and are payable only in cash. Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock.
Phantom units granted 1,628 units Grant of Phantom Stock Units on May 7, 2026
Reference price per unit $73.69 Value per Phantom Stock Unit at grant
Total phantom units after grant 60,034 units Holdings following reported transaction
Vesting date May 7, 2027 Vesting date for granted Phantom Stock Units
Underlying security 1,628 shares Underlying Eastman Chemical common stock equivalent per units
Phantom Stock Units financial
"Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share"
Phantom stock units are company promises that pay a cash or stock-equivalent award tied to the firm’s share price or value growth, but they do not issue actual shares. Think of them as a bonus check that moves with the stock like a mirror rather than handing over an ownership slice. Investors care because these awards can affect a company’s future cash obligations, executive incentives and reported expenses without causing share dilution.
Directors' Deferred Compensation Plan financial
"Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value"
restricted stock award financial
"Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid"
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
payable only in cash financial
"The Phantom Stock Units will vest on May 7, 2027, and are payable only in cash"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BEGEMANN BRETT D
(Last)(First)(Middle)
200 S. WILCOX DRIVE
(Street)
KINGSPORT TENNESSEE 37660
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Phantom Stock Units$0(1)05/07/2026A1,628(2) (1) (1)Common Stock1,628(1)$73.69(2)60,034D
Explanation of Responses:
1. Unvested Phantom Stock Units credited under the Directors' Deferred Compensation Plan, each having a value equal to the market value of one share of issuer common stock. The Phantom Stock Units will vest on May 7, 2027, and are payable only in cash.
2. Deferral at election of director of value of annual non-employee director restricted stock award that would otherwise have been paid in common stock.
Remarks:
/s/ Mark D. Austin, by Power of Attorney for Brett D. Begemann05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Eastman Chemical (EMN) report for Brett D. Begemann?

Eastman Chemical reported that director Brett D. Begemann received 1,628 Phantom Stock Units as a compensation grant. These units are credited under the Directors' Deferred Compensation Plan and are tied in value to Eastman Chemical common stock but settled only in cash upon vesting.

Are Brett D. Begemann’s Phantom Stock Units in EMN actual shares of Eastman Chemical stock?

No, the Phantom Stock Units are not actual shares of Eastman Chemical stock. Each unit tracks the market value of one share but is payable only in cash. They do not provide voting rights or direct share ownership, functioning instead as deferred cash-based compensation.

When do Brett D. Begemann’s newly granted EMN Phantom Stock Units vest and become payable?

The 1,628 Phantom Stock Units granted to Brett D. Begemann vest on May 7, 2027. Once vested, they are payable solely in cash based on the then-current market value of Eastman Chemical common stock, as specified under the Directors' Deferred Compensation Plan.

How many Eastman Chemical Phantom Stock Units does Brett D. Begemann hold after this Form 4 transaction?

After this transaction, Brett D. Begemann holds a total of 60,034 Phantom Stock Units. This total reflects his accumulated deferred director compensation awards that track Eastman Chemical’s stock price but will ultimately be settled in cash rather than through delivery of common shares.

What was the reference price used for Brett D. Begemann’s EMN Phantom Stock Unit grant?

The 1,628 Phantom Stock Units granted to Brett D. Begemann used a reference price of $73.69 per unit. Each unit has a value equal to the market value of one share of Eastman Chemical common stock on the grant date, according to the plan terms.

How were Brett D. Begemann’s EMN Phantom Stock Units created under the company’s compensation plans?

The Phantom Stock Units were created through Brett D. Begemann’s election to defer the value of his annual non-employee director restricted stock award. Instead of receiving common stock directly, that award value was credited as Phantom Stock Units under the Directors' Deferred Compensation Plan.